Pharmacogenomics and Personalised Medicine in Psychiatry
It is our pleasure and honor to welcome psychopharmacologists, geneticists and clinical psychiatrists from around the world to the CINP Thematic Meeting on Pharmacogenomics and Personalised Medicine in Psychiatry, to be held in Jerusalem, Israel on April 21-23, 2013. The last CINP (International College of Neuropsychopharmacology) meeting in Jerusalem was in 1982 and was the largest attended CINP up till that time. We expect the 2013 CINP Jerusalem to be a similar success as personalised medicine is recognised as an essential future direction in all of medicine as well as psychiatry.
The program will provide an up to date introduction to pharmacogenomics and personalised medicine in psychiatry for general psychiatrists as well as an opportunity to exchange the latest data for specialists and researchers in the area. Because of the intense interest of the pharmaceutical industry in prediction of response to psychotropic drugs and the critical importance of adverse event prediction, we expect that the Thematic Meeting will be the focus of several critical industry related events. Ethical, economic, social and legal aspects will be considered as well the implementation of personalised medicine in clinical practice.
Development of the conference program will be overseen by a strong international scientific committee and a representative local organising committee. An international call for symposium proposals will be issued and for thematic poster presentations that will be a key forum for presenting the latest data in the field.
The opportunity to visit the numerous sites in Jerusalem of religious and historical significance to so many different religions and traditions is a major plus for all our thematic meeting attendees. The psychopharmacology and psychiatric genetics research community in Israel looks forward to hosting our friends and colleagues in the unique city of Jerusalem for this exciting event.
CINP Past President
Executive Committee Liaison